After long, sometimes bitter journey, early cancer detection company Grail finally goes public

The nearly four-year journey since Illumina said it would buy Grail ends near the beginning, with Grail going public like it had planned in fall 2020.
Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks